Epithelial discoidin domain-containing receptor: Difference between revisions
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 26: | Line 26: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
*Epithelial discoidin domain-containing receptor 1; Domains – discoidin 26-186; ligand-binding 283-385; kinase 543- | *Epithelial discoidin domain-containing receptor 1; Domains – discoidin 26-186; ligand-binding 283-385; kinase 543-913 | ||
**[[5bvk]] – hDDR1 kinase domain | **[[5bvk]], [[6y23]] – hDDR1 kinase domain – human<br /> | ||
**[[3zos]], [[4bkj]], [[6bsd]] – hDDR1 kinase domain + cancer drug<br /> | **[[3zos]], [[4bkj]], [[6bsd]] – hDDR1 kinase domain + cancer drug<br /> | ||
**[[6few]] – hDDR1 kinase domain + alport syndrome drug<br /> | **[[6few]] – hDDR1 kinase domain + alport syndrome drug<br /> | ||
**[[6fex]], [[6fil]],[[6fin]], [[6fio]], [[6fiq]] – hDDR1 kinase domain (mutant) + alport syndrome drug<br /> | **[[6fex]], [[6fil]],[[6fin]], [[6fio]], [[6fiq]] – hDDR1 kinase domain (mutant) + alport syndrome drug<br /> | ||
**[[4ckr]], [[5bvn]], [[5bvo]], [[5bvw]], [[5fdp]], [[5fdx]], [[6brj]], [[6gwr]], [[6hp9]] – hDDR1 kinase domain + inhibitor<br /> | **[[4ckr]], [[5bvn]], [[5bvo]], [[5bvw]], [[5fdp]], [[5fdx]], [[6brj]], [[6gwr]], [[6hp9]], [[7bcm]], [[7be6]] – hDDR1 kinase domain + inhibitor<br /> | ||
**[[4ag4]] – hDDR1 29-367 domain + antibody<br /> | **[[4ag4]] – hDDR1 29-367 domain + antibody<br /> | ||
Line 39: | Line 39: | ||
**[[2z4f]] – hDDR2 discoidin domain – NMR<br /> | **[[2z4f]] – hDDR2 discoidin domain – NMR<br /> | ||
**[[2wuh]] – hDDR2 discoidin domain + collagen<br /> | **[[2wuh]] – hDDR2 discoidin domain + collagen<br /> | ||
**[[6fer]] – hDDR2 kinase domain + inhibitor<br /> | **[[6fer]], [[7aym]] – hDDR2 kinase domain + inhibitor<br /> | ||
}} | }} | ||
== References == | == References == |